Business
Costas, Inc. Reports Q2 2023 Results And S1 Progress.
Costas, Inc. Reports Q2 2023 Results And S1 Progress..
About this update from Standard Dental Labs Inc.
[{"type":"text","content":"ORLANDO, FLORIDA, USA, July 27, 2023 -- Costas, Inc. (OTCMKTS: CSSI) (\"CSSI\" or \"the Company\"), doing business as Standard Dental Labs Inc. (SDL), continues to perform, reporting gross profit margins in excess of 40%, over the past 3 quarters.Gross profits stem from the company’s focus on the manufacture of dental implants, dental prosthetics, and other dental lab services and products. The company is committed to growing the business through the acquisition of similar dental labs in the Orlando, Florida area, and plans to continue acquisitions of dental labs on an ongoing basis.SDL dental lab operations are one part of the business that continues on a steady course. While the company continues its manufacturing business, the anticipated approval of the S1 will provide the framework to acquire many more labs in the Orlando, Florida area in the coming months. Lab acquisitions will continue immediately following its approval, which will allow management to further the company’s business plan of identifying a suitable location in which to consolidate the newly acquired labs, including the previously acquired Prime Dental Lab.The fastest path to growth is the acquisition model. This model has been used in many other industries, and with great success. The consolidation of large pharma spawned a new era of acquisition-based growth in the early 1970s, with many significant market consolidations left to be made. Standard Dental Labs Inc. (OTC:CSSI) is focused on consolidating in the US Dental Lab Industry. The consolidation of dental practices is accelerating, and despite incredible success by consolidators, the competition is also significant.The pharmaceutical industry is regularly in the headlines for mega-mergers and acquisitions; however, in many other industries, mergers are done quietly and behind closed doors. Industries most significant to SDL are dental and medical clinics. Increasing M&A activity in these industries offers great insight and a roadmap for Standard Dental Labs' forward momentum.From March of 2022, this quote describes incredible liquidity delivered to investors and the dentists themselves. Standard Dental Labs is effectively replicating this, but to date, we have yet to be able to identify any competition.“In the last 60 days of 2021, invisible dental support organizations (IDSOs) monetized more than $...